ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.

NSC Compound Enrichment Correlation
NSC 755264 Null 0.0457230037898008 0.28299201
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.0457230037898008 0.10669001
NSC 84092 Null 0.0457230037898008 0.45205751
NSC 86368 Null 0.0457230037898008 0.38014727
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 2.27718602463644e-005 0.63192799
NSC 618939 Camptothecin Derivative 2.27718602463644e-005 0.63922335
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 2.27718602463644e-005 0.72843495
NSC 735037 Camptothecin Derivative 2.27718602463644e-005 0.6266568
NSC 697726 RH1 5.16163525082862e-005 0.61087331
NSC 132313 Dianhydrogalactitol 6.13985294021483e-005 0.63055279
Total:67  Current:66    [First] [Prev] [Next] [Last]